126 related articles for article (PubMed ID: 2360470)
21. Divergent mechanisms of ATP-sensitive K+ channel-induced vasodilation in renal afferent and efferent arterioles. Evidence of L-type Ca2+ channel-dependent and -independent actions of pinacidil.
Reslerova M; Loutzenhiser R
Circ Res; 1995 Dec; 77(6):1114-20. PubMed ID: 7586223
[TBL] [Abstract][Full Text] [Related]
22. The effects of HA1077, a novel protein kinase inhibitor, on reductions of cerebral blood flow and glucose metabolism following acute and/or chronic bilateral carotid artery ligation in Wistar rats.
Tsuchiya M; Sako K; Yonemasu Y; Asano T
Exp Brain Res; 1993; 97(2):233-8. PubMed ID: 8150043
[TBL] [Abstract][Full Text] [Related]
23. Ketamine directly dilates bovine cerebral arteries by acting as a calcium entry blocker.
Wendling WW; Daniels FB; Chen D; Harakal C; Carlsson C
J Neurosurg Anesthesiol; 1994 Jul; 6(3):186-92. PubMed ID: 8081099
[TBL] [Abstract][Full Text] [Related]
24. Enhancement by neuropeptide Y (NPY) of the dihydropyridine-sensitive component of the response to alpha 1-adrenoceptor stimulation in rat isolated mesenteric arterioles.
Andriantsitohaina R; Stoclet JC
Br J Pharmacol; 1990 Feb; 99(2):389-95. PubMed ID: 1970270
[TBL] [Abstract][Full Text] [Related]
25. Inhibition by the protein kinase inhibitor HA1077 of the activation of NADPH oxidase in human neutrophils.
Arai M; Sasaki Y; Nozawa R
Biochem Pharmacol; 1993 Oct; 46(8):1487-90. PubMed ID: 8240400
[TBL] [Abstract][Full Text] [Related]
26. HA-1077 suppress both proliferation of vascular smooth muscle cells and c-fos mRNA induction.
Sase K; Yui Y; Hattori R; Shirotani M; Kawai C; Sasayama S
Jpn Circ J; 1992 Dec; 56(12):1229-33. PubMed ID: 1479648
[TBL] [Abstract][Full Text] [Related]
27. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of pressure-induced myogenic contraction and tyrosine phosphorylation by fasudil, a cerebral vasodilator, in rat cerebral artery.
Masumoto N; Tanabe Y; Saito M; Nakayama K
Br J Pharmacol; 2000 May; 130(2):219-30. PubMed ID: 10807658
[TBL] [Abstract][Full Text] [Related]
29. Possible mechanism of the potent vasoconstrictor responses to ryanodine in dog cerebral arteries.
Asano M; Kuwako M; Nomura Y; Suzuki Y; Shibuya M; Sugita K; Ito K
Eur J Pharmacol; 1996 Sep; 311(1):53-60. PubMed ID: 8884236
[TBL] [Abstract][Full Text] [Related]
30. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Altura BM; Altura BT
Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles.
Lang MG; Paternò R; Faraci FM; Heistad DD
Stroke; 1997 Jan; 28(1):181-5. PubMed ID: 8996509
[TBL] [Abstract][Full Text] [Related]
32. Effects of calcium antagonists on isolated bovine cerebral arteries: inhibition of constriction and calcium-45 uptake induced by potassium or serotonin.
Wendling WW; Harakal C
Stroke; 1987; 18(3):591-8. PubMed ID: 3590251
[TBL] [Abstract][Full Text] [Related]
33. HA1077, a protein kinase inhibitor, inhibits calponin phosphorylation on Ser175 in porcine coronary artery.
Nagumo H; Seto M; Sakurada K; Walsh MP; Sasaki Y
Eur J Pharmacol; 1998 Nov; 360(2-3):257-64. PubMed ID: 9851593
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.
Satoh S; Ikegaki I; Suzuki Y; Asano T; Shibuya M; Hidaka H
Br J Pharmacol; 1996 Aug; 118(7):1592-6. PubMed ID: 8842419
[TBL] [Abstract][Full Text] [Related]
35. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
Carvalho CA; Coutinho OP; Carvalho AP
J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
[TBL] [Abstract][Full Text] [Related]
36. New pharmacological strategies in vascular diseases: a novel intracellular calcium antagonist, HA1077 (AT-877) and cerebral vasospasm.
Asano T; Hidaka H
Methods Find Exp Clin Pharmacol; 1990; 12(6):443-8. PubMed ID: 2087143
[No Abstract] [Full Text] [Related]
37. Low-dose combination of Rho kinase and L-type Ca(2+) channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction.
Porras-González C; González-Rodríguez P; Calderón-Sánchez E; López-Barneo J; Ureña J
Eur J Pharmacol; 2014 Jun; 732():130-8. PubMed ID: 24680953
[TBL] [Abstract][Full Text] [Related]
38. Comparative cardiovascular actions of clentiazem, diltiazem, verapamil, nifedipine, and nimodipine in isolated rabbit tissues.
Mecca TE; Love SD
J Cardiovasc Pharmacol; 1992 Oct; 20(4):678-82. PubMed ID: 1280727
[TBL] [Abstract][Full Text] [Related]
39. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function.
Asano T; Hidaka H
J Pharmacol Exp Ther; 1984 Oct; 231(1):141-5. PubMed ID: 6436469
[TBL] [Abstract][Full Text] [Related]
40. Triphasic response of rat intracerebral arterioles to increasing concentrations of vasopressin in vitro.
Takayasu M; Kajita Y; Suzuki Y; Shibuya M; Sugita K; Ishikawa T; Hidaka H
J Cereb Blood Flow Metab; 1993 Mar; 13(2):304-9. PubMed ID: 8436623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
